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Abstract The relation of alcohol consumption with dis-
ease burden remains debated partly due to opposite
associations with cardiovascular disease (CVD) and can-
cer. The relation of alcohol consumption with disease
burden expressed in disability-adjusted life years
(DALYs) summarizes opposing associations of alcohol
consumption on chronic diseases. This study aimed to
investigate the association of alcohol consumption with
chronic disease burden expressed in DALYs based on
individual-participant data. The study was a prospective
study among 33,066 men and women from the EPIC-NL
cohort. At baseline, alcohol consumption was assessed
with a validated food-frequency questionnaire. Partici-
pants were followed for occurrence of and mortality from
chronic diseases and DALYs were calculated. After
12.4 years follow-up, 6647 disease incidences and 1482
deaths were documented, resulting in 68,225 healthy
years of life lost (6225 DALYs). Moderate drinkers
(women 5–14.9 g/day, men 5–29.9 g/day) had a lower
chronic disease burden (mean DALYs -0.27; 95% CI
-0.43; -0.11) than light drinkers (0–4.9 g/day), driven
by a lower disease burden due to CVD (-0.18: -0.29;
-0.06) but not cancer (-0.05: -0.16; 0.06). The asso-
ciations were most pronounced among older participants
(C50 years; -0.32; -0.53; -0.10) and not observed
among younger women (-0.08; -0.43; 0.35), albeit non-
significant (pinteraction[ 0.14). Substantial drinking
(women 15–29.9 g/day, men 30–59.9 g/day) compared to
light drinking was not associated with chronic disease
burden. Our results show that moderate compared to light
alcohol consumption was associated with living approxi-
mately 3 months longer in good health. These results
were mainly observed among older participants and not
seen among younger women.
Keywords Alcohol consumption  Disability-adjusted life
years  Chronic disease burden  Cancer  Cardiovascular
disease
Introduction
Moderate alcohol consumption, 1–2 drinks per day [1–4],
has been associated with a reduced risk of all-cause mor-
tality in prospective cohort studies compared to abstainers
and heavier drinkers [5]. This reduced risk is ascribed to a
reduced risk of cardiovascular diseases with moderate
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alcohol consumption [6, 7], but remains disputed [8].
Conversely, any amount of alcohol consumption increases
the risk of different types of cancer [9, 10]. Alcohol con-
sumption is linearly associated with an approximately 10%
increased risk of breast cancer with each drink per day [9].
These opposing associations of alcohol consumption with
different chronic diseases emphasizes the importance of
investigating the relation of alcohol consumption with total
disease burden, which can be estimated with disability-
adjusted life years (DALYs).
To date, DALYs have mainly been calculated on a
population level based on surveillance data of disease
incidence and mortality, like in the Global Burden of
Disease Study (GBD) [11]. In those studies, risk factors
such as alcohol consumption are related to DALYs based
on effect sizes from observational or intervention studies.
According to the GBD of 2010, alcohol use accounted for
up to 5% of the global disease burden, but this estimate
differed over different populations and regions [11].
However, the GBD studies provides a population estimate
that may be influenced by different drinking patterns of
populations. For example, the burden of alcohol use was
greater among men than women and particularly high in
certain regions such as Eastern Europe [11]. This can be
explained by women drinking less on average than men. In
addition, the higher contribution of injury due to alcohol
use stronger affects men than women but also explains
higher disease burden in certain regions like Eastern Eur-
ope [12–15].
We previously calculated DALYs at an individual level
for participants of the EPIC-NL cohort who were followed
for disease occurrence to study the relation between life-
style factors and disease burden [16, 17]. We now use this
approach to account for opposing associations of alcohol
consumption with chronic diseases, including the influence
of dosage and adjustment for confounding. We will also
address effect modification by sex and age.
Methods
EPIC-NL study
The EPIC-NL study consists of the two Dutch contribu-
tions to the European Prospective Investigation into Cancer
and Nutrition (EPIC), which were set up simultaneously
between 1993 and 1997 [18]. In brief, the Prospect-EPIC
study includes 17,357 women (49–70 years) who partici-
pated in the Dutch breast cancer screening programme. The
MORGEN-EPIC cohort consists of 22,654 men and
women (20–65 years) from random samples of the popu-
lation in three Dutch towns (Doetinchem, Amsterdam and
Maastricht). At baseline, a general questionnaire and a
food-frequency questionnaire (FFQ) were administered and
a physical examination was performed. This study was
conducted according to the Declaration of Helsinki and
approved by the local institutional review boards. Written
informed consent was obtained from all subjects.
From the total cohort (n = 40,011), participants without
permission for linkage with disease registries were exclu-
ded (n = 2879). Participants with any of the studied dis-
eases at baseline [Cancer, Coronary Heart Disease (CHD),
Stroke, Diabetes Mellitus, Chronic Obstructive Pulmonary
Disease (COPD), Asthma, Parkinson’s disease, Rheuma-
toid Arthritis, Osteoarthritis, and Inflammatory Bowel
Disease (IBD)] (n = 3625) were excluded. We also
excluded subjects with missing information from the FFQ
on alcohol consumption and dietary intake (n = 142) or
with implausible high or low scores for total energy intake
(those in the top 0.5% and bottom 0.5% of the ratio of
reported energy intake over estimated energy requirement
based on basal metabolic rate) (n = 299), leaving 33,066
men and women for analysis.
Alcohol consumption
Alcohol consumption was assessed by the general ques-
tionnaire and a food frequency questionnaire (FFQ). The
FFQ contained questions on the usual frequency of con-
sumption of 79 main food items during the year preceding
enrolment [19, 20]. This questionnaire allowed the esti-
mation of the average daily consumption of 178 foods,
including alcoholic beverages. The relative validity of
alcohol consumption measured with the FFQ is good as
confirmed by a Spearman correlation of 0.87 between the
FFQ and the average of 12 monthly 24-h recalls [19, 20].
Subjects were asked whether they formerly or currently
used alcohol. If doing so currently, they were asked the
number of units of beer, white wine, red wine, port/sh-
erry/vermouth and spirits consumed. Subjects indicated
their consumption frequency on a daily/weekly/monthly/
yearly scale or as never consumed. Alcohol consumption
was determined based on the FFQ by multiplying the
amount of each beverage consumed by their alcohol
content using the standard ethanol weight content (5% for
beer, 18.5% for fortified wine, 12.5% for red wine, 12%
for white wine and 40% for liquor; means from the
average type of beverages) and was categorized into 5
categories of total alcohol consumption; lifetime abstain-
ers, former drinkers, light drinkers (0–4.9 g/day), moder-
ate drinkers (5–14.9 g/day for women, 5–29.9 g/day for
men), and substantial drinkers (C15 g/day for women and
C30 g/day for men). Substantial drinkers were further
subdivided into heavy drinkers (15–29.9 g/day for
women, 30–59.9 g/day for men) and excessive drinkers
(C30 for women, C60 for men).
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Covariates
The general questionnaire included questions on presence
of risk factors for chronic diseases, like smoking status and
intensity (categorized as never; former: quit smoking
[20 years ago, quit 10–20 years ago, quit B10 years ago;
current smoker 1–15 cigarettes/day, 16–25 cigarettes/day,
[25 cigarettes/day; pipe or cigar smoker) and level of
education [categorized as very low (only primary school),
low (lower vocational education), middle (secondary
school or intermediate vocational training) or high (higher
vocational training or university)]. Usual dietary intake was
obtained from the validated FFQ and was used to score
intake of eight components of a Mediterranean-style Diet:
vegetables; legumes; fruit, nuts and seeds; cereals; fish; the
ratio of unsaturated to saturated fatty acids; meat; and dairy
products [21]. Physical activity was assessed using the
EPIC physical activity questionnaire and categorized
according to the validated Cambridge Physical Activity
Index (CPAI) [22, 23] in 4 categories (inactive, moderately
inactive, moderately active or active). Missing data on
physical activity (14%), smoking status (0.4%), educa-
tional level (0.8%), and/or BMI (0.1%) was imputed using
single linear regression modelling (SPSS MVA procedure).
Endpoint assessment
Participants were followed for mortality and morbidity
through linkage with several registries. The selection of the
diseases was based on their prevalence and disease burden
in the Netherlands, but also on the availability of data
sources. Information on vital status and the date of death
was obtained through linkage with municipal registries.
Causes of death were obtained from Statistics Netherlands.
Information on disease occurrence (Cancer, CHD, Stroke,
Diabetes Mellitus, COPD, Asthma, Parkinson’s disease,
Rheumatoid Arthritis, Osteoarthritis, and IBD) was
obtained from the National Cancer Registry and the
national hospital discharge diagnosis database from the
Dutch National Medical Registry. The National Cancer
Registry provided information on the type of cancer and
the date of histological diagnosis. The national hospital
discharge diagnosis database provided the date of diagnosis
for CHD, stroke, Diabetes Mellitus, COPD, Asthma,
Parkinson’s disease, Rheumatoid Arthritis, Osteoarthritis,
and IBD. The national hospital discharge diagnosis data-
base was linked to the cohort with a validated probabilistic
method [24]. Self-report and urinary glucose strip tests
provided additional information on diabetes. Diabetes
cases were verified against information of the general
practitioner or pharmacist [25]. Follow-up was complete
until 31 December 2007.
Computation of DALYs
DALYs, i.e. the sum of the Years Lost due to Disability
(YLD) and the Years of Life Lost due to premature mor-
tality (YLL) [26], were calculated for each individual in the
cohort as previously described [17]. The YLL were com-
puted as the number of years that death occurred earlier
than expected. The expected number of life years (life
expectancy) are the remaining years that a person of a
certain age is expected to live on average defined at the
time of death, loss of follow-up or end of follow-up [17].
The expected life expectancy was obtained from Statistics
Netherlands that provides age, sex and calendar year
specific life expectancies based on mortality rates [27]. The
YLD are calculated by the number of years a person lives
with a disability multiplied by a disability weight reflecting
the severity of that disability. The disability weights were
derived from the Dutch Disability Weight study [28]. The
disability weights can range between zero (no burden, i.e.
full health) and one (death) (Supplemental Table 1). The
years lived with a chronic disease are calculated from the
disease onset until death or until the end of life expectancy.
One DALY represents the loss of one year in full health.
For example, a person who lived five years with diabetes
(disability weight 0.20) and died 30 years before his life
expectancy obtains one YLD and 30 YLL which equals 31
healthy years of life lost (31 DALYs) (Fig. 1). Total
DALYs were computed, as well as DALYs for specific
diseases: CHD, CVD (includes CHD and stroke), and
cancer. DALYs from cancer were further separated into
alcohol-related (the upper aero-digestive tract, breast, liver,
Fig. 1 Example of DALY
calculation (Reproduced from
Struijk et al. [17])
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and colorectal cancer) and non-alcohol related cancer.
DALYs for participants that suffered from both alcohol-
and non-alcohol-related cancers were included in the
alcohol-related cancer DALYs. Potentially alcoholism-re-
lated disorders were not included, since several of these
disorders were not chronic and occurred in less than 1% of
our cohort. However, to explore the influence of these
disorders on the association between alcohol consumption
and total disease burden, we conducted a sensitivity anal-
ysis as a worst-case scenario. For this analysis, we assumed
that all of these disorders were chronic. Thus, in this
analysis, disorders with a transient nature such as delirium
and psychosis were assumed to be present from the date of
first diagnosis onwards. The following potentially alco-
holism-related disorders were included in these analyses
and obtained from the hospital discharge diagnosis data-
base: alcohol dependence, delirium, liver cirrhosis, psy-
chosis and mental disorders.
Statistical analysis
Due to the distribution of the DALYs, i.e. a peak at 0 and a
normal distribution in participants with DALYs[ 0, we
used a two-part model to estimate the association of alco-
hol intake with DALYs as dependent variable [29]. This
two-part model combines the estimation of the probability
of having DALYs using logistic regression with the esti-
mation of the number of DALYs among participants with
DALYs[ 0 using linear regression. Alcohol intake was
analyzed categorically, using light drinkers (0–5 g/day) as
the reference. Confidence intervals were constructed with
bootstrapping (500 samples). A quadratic P for trend was
investigated by applying a regression with quadratic con-
trast coefficients to DALY estimates of each of the cate-
gories, excluding lifetime abstainers and former drinkers,
in all bootstrapping samples. The P value was the per-
centage of positive (or negative, depending on the direction
of the association) regression coefficients of the bootstrap
times two because of two sided testing.
The analyses were adjusted for age, sex, physical
activity level, education level, smoking status and intensity
and energy intake (kcal/day). In a second model, BMI
(continuous) and diet (continuous mMDS score) were
included as covariates. We investigated whether associa-
tions differed across strata of age and sex by including an
interaction term in the logistic and linear model and by
stratifying the analyses by sex and age ([50/B50 years).
To exclude possible residual confounding by smoking, the
analyses were repeated among never-smokers only. To
explore the influence of alcoholism-related disorders, the
analyses were repeated while including these disorders in
the DALY calculation. Statistical analyses were conducted
using SAS 9.2 (SAS Institute, Cary, US) and SPSS 14.0
(Chicago, IL, USA).
Results
The percentage of men was higher for moderate (42%) and
heavy (31%) drinkers than light drinkers (14%). Further-
more, moderate and heavy drinkers were higher educated,
had a slightly lower BMI, smoked more often and had a
higher energy intake than light drinkers (Table 1). After a
median follow-up of 12.4 years, 6647 disease incidences
and 1482 deaths were documented. During follow-up,
68,225 healthy years of life (DALYs) were lost.
In crude analyses, moderate alcohol consumption was
associated with a significantly lower total disease burden
(mean DALYs -0.42; 95% CI -0.55; -0.28) compared
with light drinkers (Table 2). Adjusting these analyses for
confounders did not substantially alter the results for
moderate drinkers. Moderate drinkers still had a signifi-
cantly lower total disease burden (mean DALYs -0.27;
95% CI -0.43; -0.11). This corresponds to living
approximately 3 months longer in good health for moder-
ate drinkers. When separating DALY’s due to CVD and
cancer, moderate alcohol consumption was only associated
with a lower disease burden from cardiovascular causes
(mean DALYs -0.18; 95% CI -0.29; -0.06), but not from
cancer (mean DALYs -0.05; 95% CI -0.16; 0.06)
(Table 2). In crude analysis, substantial drinking was not
associated with total disease burden (mean DALYs 0.02;
95% CI -0.13; 0.18). After multivariable adjustment,
substantial drinking was associated with a lower total dis-
ease burden (mean DALYs -0.18; 95% CI -0.35; 0.00)
(Table 2). Exchanging BMI for waist circumference in the
model did not substantially alter the results (data not
shown).
When subdividing substantial drinkers into heavy and
excessive drinkers, the association with lower total disease
burden attenuated at higher levels of intake (Table 3).
Excessive alcohol consumption was not associated with
total DALYs (mean DALYs -0.02; 95% CI -0.28; 0.27)
adjusted for confounders. Separating these analyses for
DALYs due to CVD and cancer showed that excessive
compared to light alcohol consumption remained associ-
ated with a lower CVD disease burden (mean DALYs
-0.21; -0.40; -0.01), but with a slightly higher cancer
disease burden (mean DALYs 0.08; 95% CI -0.11; 0.29).
Finally, separating DALYs from cancer into alcohol-re-
lated and non-alcohol related cancer showed that excessive
alcohol consumption was significantly associated with a
higher disease burden from alcohol-related cancer (mean
DALYs 0.11; 95% CI 0.01; 0.21), but not associated with
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Table 1 Characteristics of 33,066 EPIC-NL participants at recruitment according to alcohol consumption categories
Alcohol intake categories
Lifetime
abstainer
Former
drinker
Light 0 to
\5 g/day
Moderate Heavy Excessive
Women 5 to
\15 g/day
Women 15 to
\30 g/day
Women
C30 g/day
Men 5 to\30 g/day Men 30 to\60 g/day Men C 60 g/day
Total, N 2267 363 13,831 9983 4589 2033
Women (%) 79 52 86 58 69 83
Age at recruitment
(years)
43 ± 13 46 ± 11 50 ± 12 47 ± 12 50 ± 10 52 ± 8
BMI (kg/m2) 26.1 ± 4.6 25.5 ± 4.2 25.9 ± 4.2 25.3 ± 3.6 25.2 ± 3.5 25.2 ± 3.7
Waist circumference
(cm)
85 ± 12 87 ± 13 84 ± 11 86 ± 11 85 ± 11 85 ± 11
High education (%) 10 18 14 28 29 29
Physically active (%) 39 44 42 45 41 38
Current smokers (%) 27 36 24 32 39 53
Energy intake
(kcal/day)
2019 ± 611 2181 ± 700 1922 ± 541 2203 ± 644 2513 ± 623 2164 ± 615
Alcohol intake (g/day)
(median IQR)
0 (0) 0 (0) 1 (2) 10 (7) 24 (12) 41 (26)
mMDS 3.8 ± 1.5 4.1 ± 1.6 3.9 ± 1.5 4.1 ± 1.5 4.1 ± 1.5 4.0 ± 1.5
Women, N 1784 187 11,888 5747 3187 1691
Age at recruitment
(years)
43 ± 13 46 ± 12 52 ± 12 50 ± 11 52 ± 9 53 ± 8
BMI (kg/m2) 26.2 (4.8) 24.9 (4.3) 25.9 (4.3) 25.0 (3.7) 24.9 (3.4) 25.1 (3.7)
Waist circumference
(cm)
84 (12) 82 (11) 83 (11) 81 (10) 81 (9) 83 (10)
High education (%) 8 21 13 25 28 29
Physically 7active (%) 37 41 42 44 41 37
Current smokers (%) 27 32 22 28 35 50
Energy intake
(kcal/day)
1906 ± 530 1844 ± 480 1828 ± 459 1906 ± 449 1916 ± 441 2002 ± 450
Alcohol intake, g/day
(median IQR)
0 (0) 0 (0) 1 (2) 9 (5) 21 (6) 38 (14)
mMDS 3.8 ± 1.4 4.2 ± 1.6 3.9 ± 1.5 4.1 ± 1.5 4.1 ± 1.5 4.1 ± 1.5
Men, N 483 176 1943 4236 1402 342
Age at recruitment
(years)
41 ± 12 46 ± 10 42 ± 12 42 ± 11 45 ± 10 46 ± 9
BMI (kg/m2) 25.8 (3.6) 26.2 (4.0) 25.6 (3.6) 25.6 (3.3) 26 (3.4) 25.9 (3.9)
Waist circumference
(cm)
92 (11) 94 (12) 91 (11) 92 (10) 94 (10) 95 (11)
High education (%) 15 15 20 32 31 29
Physically active (%) 45 48 47 47 41 39
Current smokers (%) 28 41 32 36 49 65
Energy intake
(kcal/day)
2439 ± 701 2538 ± 720 2495 ± 642 2606 ± 648 2692 ± 641 2964 ± 695
Alcohol intake (g/day)
(median IQR)
0 (0) 0 (0) 2 (3) 14 (11) 39 (13) 75 (24)
mMDS 3.9 ± 1.6 4.0 ± 1.6 3.9 ± 1.4 4.0 ± 1.5 4.0 ± 1.5 3.7 ± 1.4
mMDS modified Mediterranean Diet Score
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disease burden from non-alcohol related cancer (mean
DALYs -0.04; 95% CI -0.20; 0.14).
In a sensitivity analysis including alcoholism-related
disorders, the association between moderate alcohol con-
sumption and lower total disease burden did not materially
change (mean DALYs -0.26; 95% CI -0.42; -0.10).
Substantial drinking still was not associated with total
disease burden (mean DALYs -0.12; 95% CI -0.31;
0.07), but the estimate was substantially attenuated.
Excessive drinking was related with a higher total disease
burden, albeit statistically non-significant (mean DALYs
0.12; 95% CI -0.17; 0.45). Substantial drinking was
associated with a significantly higher disease burden for
alcoholism-related disorders (mean DALYs 0.10; 95% CI
0.06; 31.4).
Stratified by age (Table 4), moderate alcohol con-
sumption was more strongly associated with a lower total
disease burden among older participants (C50 years; mean
DALYs -0.32; 95% CI -0.53; -0.10), than among
younger participants (\50 years; mean DALYs -0.14;
95% CI -0.38; 0.06), although the interaction between age
and alcohol was not statistically significant (p[ 0.14).
Results did not differ between men and women
(pinteraction[ 0.40). Stratifying by age and sex showed that
the lower total disease burden with moderate alcohol
consumption was present among older women only, but not
among younger women (mean DALYs -0.08; 95% CI
-0.43; 0.35).
Repeating the analyses among never-smokers only
(2700 men and 10,080 women), similar results were
obtained for moderate drinkers (mean DALYs -0.24; 95%
CI -0.48; -0.04), but no significant associations for other
alcohol consumption categories.
Discussion
This study investigated the relation of alcohol consumption
with chronic disease burden, thus summarizing opposing
associations of alcohol with different diseases. We found
that moderate alcohol consumption (5–14.9 g/day for
women, 5–29.9 g/day for men) was associated with a lower
total disease burden compared to light consumption
(0–4.9 g/day). This association was mainly observed
among women and older participants and driven by a lower
disease burden due to CVD. No association was observed
Table 2 Mean (±SE) DALYs lost and regression coefficients (95% CI) of different alcohol consumption categories with DALYs in 33,066
EPIC-NL participants
Alcohol intake categories
Lifetime abstainer Former drinker Light 0–\5 g/day Moderate Substantial Quadratic
P for trendWomen 5–\15 g/day Women C15 g/day
Men 5–\30 g/day Men C30 g/day
N 2267 363 13,831 9983 6622
DALY total 4534 1050 30,428 17,969 14,568
Mean DALY (SD) 2.0 (5.2) 2.9 (6.9) 2.2 (5.2) 1.8 (4.8) 2.2 (5.4)
Crude -0.22 (-0.45; -0.00) 0.73 (0.06; 1.44) Reference -0.42 (-0.55; -0.28) 0.02 (-0.13; 0.18) \0.01
Adjusted 1a 0.22 (-0.08; 0.52) 0.74 (-0.01; 1.52) Reference -0.31 (-0.48; -0.15) -0.22 (-0.40; -0.04) 0.008
Adjusted 2b 0.16 (-0.13; 0.46) 0.81 (0.03; 1.59) Reference -0.27 (-0.43; -0.11) -0.18 (-0.35; -0.00) 0.02
DALY coronary heart disease
Mean DALY
Crude 0.00 (-0.08; 0.09) 0.28 (-0.01; 0.56) Reference -0.03 (-0.09; 0.02) -0.01 (-0.08; 0.04) 0.33
Adjusted 1a 0.06 (-0.11; 0.23) 0.07 (-0.27; 0.41) Reference -0.15 (-0.24; -0.06) -0.18 (-0.28; -0.09) 0.14
Adjusted 2b 0.04 (-0.12; 0.22) 0.08 (-0.26; 0.41) Reference -0.14 (-0.23; -0.05) -0.17 (-0.27; -0.07) 0.18
DALY cardiovascular disease (coronary heart disease ? stroke)
Mean DALY
Crude -0.02 (-0.14; 0.10) 0.31 (-0.04; 0.69) Reference -0.09 (-0.16; -0.02) -0.01 (-0.09; 0.07) 0.01
Adjusted 1a 0.08 (-0.14; 0.32) 0.17 (-0.29; 0.66) Reference -0.19 (-0.30; -0.07) -0.19 (-0.31; -0.05) 0.08
Adjusted 2b 0.06 (-0.15; 0.29) 0.19 (-0.28; 0.66) Reference -0.18 (-0.29; -0.06) -0.18 (-0.29; -0.04) 0.10
DALY cancer
Mean DALY
Crude -0.25 (-0.39; -0.11) 0.13 (-0.30; 0.60) Reference -0.14 (-0.23; -0.06) 0.07 (-0.04; 0.17) \0.01
Adjusted 1a -0.09 (-0.28; 0.12) 0.21 (-0.33; 0.78) Reference -0.06 (-0.17; 0.05) -0.05 (-0.17; 0.06) 0.51
Adjusted 2b -0.10 (-0.29; 0.11) 0.22 (-0.33; 0.80) Reference -0.05 (-0.16; 0.06) -0.04 (-0.17; 0.07) 0.54
a Adjusted model 1 is adjusted for age, sex, physical activity, education, energy intake, smoking status and intensity
b Adjusted model 2 = model 1 ? bmi ? mMDS
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among younger women. Substantial alcohol consumption
was not associated with burden from chronic diseases.
However, excessive alcohol consumption was associated
with higher disease burden from alcohol-related cancer.
The main strength of our study is its prospective design
with a summary health measure as outcome. However,
several limitations need to be addressed. Left and right
truncation of the cohort may have led to an underestimation
of the true association between alcohol consumption and
chronic disease burden [17]. Participants who were still
alive at the end of follow-up were assumed to stay in the
same state of health until their expected age of death. In
reality, part of the participants who were still disease-free
at the end of follow-up will develop disease or die before
the expected age. This is not accounted for in the current
analysis. For those living with a disease at the end of fol-
low-up, DALYs may be underestimated as well, since their
life expectancy is assumed to be similar to that of a healthy
person, while they are likely to die earlier. Due to the
relatively healthy cohort and exclusion of participants with
prevalent diseases at baseline, many participants (79%)
were still disease-free at the end of follow-up. Although we
included several potentially alcoholism-related disorders in
a sensitivity analysis, underestimation of the association for
substantial consumption may still be present due to the
inability to include Alzheimer’s disease, depression and
alcohol-related ‘diseases’ such as injuries for which
disability weights are not available. Furthermore, the
number of some of the included diseases may be under-
estimated because these were based on hospital discharge
diagnoses, which includes only severe cases needing hos-
pitalization. Finally, disease burden was based on an
observation time of 12 years. So, the total number of
DALYs will be underestimated. Due to the non-linear
relation, it is not clear how these relate to alcohol con-
sumption and thus to predict its effect on the observed
relations. Another limitation is the self-reported alcohol
intake data, although alcohol consumption from the FFQ
correlated well with the result of twelve monthly 24-h
recalls [19, 20]. Also, we had relatively few excessive
drinkers in our cohort and we could not account for
drinking patterns like binge drinking. However, binge
drinking does not frequently occur among middle-aged or
older persons ([55 years) [30]. It is therefore unlikely that
this has influenced the results in this cohort of predomi-
nantly middle-aged and older women to a large extent.
Furthermore, we studied relations with disease burden;
societal consequences of alcohol consumption were not
included. Finally, we cannot rule out the possibility of
residual confounding, as in any observational study.
So far DALYs were mainly used in GBD studies, which
aim to define the health status in (different parts of) the
world and over time, using population data and modeling
techniques. According to the GBD Study of 2010, alcohol
Table 4 Mean (± SE) DALYs lost and regression coefficients (95% CI)a of different alcohol consumption categories with DALYs in 33,066
EPIC-NL participants of the EPIC-NL cohort, stratified by age group and sex
Alcohol intake categories
Lifetime abstainer Former drinker Light
0–\5 g/day
Moderate Substantial Quadratic p for
trendWomen 5–\15 g/day Women C15 g/day
Men 5–\30 g/day Men C30 g/day
DALY total
\50 years 0.02 (-0.31; 0.35) 1.33 (0.41; 2.36) Reference -0.14 (-0.38; 0.06) -0.04 (-0.31; 0.21) 0.22
C50 years 0.19 (-0.23; 0.59) 0.02 (-0.94; 1.09) Reference -0.32 (-0.53; -0.10) -0.26 (-0.49; -0.03) 0.10
DALY total
men -0.15 (-0.68; 0.46) 0.78 (-0.19; 1.85) Reference -0.31 (-0.67; 0.02) -0.18 (-0.59; 0.18) 0.05
women 0.22 (-0.10; 0.54) 0.56 (-0.54; 1.72) Reference -0.25 (-0.42; -0.06) -0.18 (-0.35; 0.01) 0.06
DALY total
\50 years,
men
-0.11 (-0.77; 0.59) 1.30 (0.04; 2.62) Reference -0.26 (-0.68; 0.11) -0.32 (-0.77; 0.11) 0.56
C50 years,
men
-0.20 (-1.20; 1.09) 0.12 (-1.38; 1.66) Reference -0.28 (-0.89; 0.28) 0.15 (-0.55; 0.78) 0.35
\50 years,
women
0.06 (-0.35; 0.54) 1.09 (-0.19; 3.47) Reference -0.08 (-0.43; 0.35) 0.13 (-0.25; 0.55) 0.35
C50 years,
women
0.30 (-0.13; 0.73) 0.11 (-1.21; 1.50) Reference -0.28 (-0.47; -0.05) -0.28 (-0.51; -0.04) 0.22
a Adjusted for age, sex, physical activity, education, energy intake, smoking status and intensity, BMI and mMDS
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use accounted for up to 5% of the global disease burden
[11], ranging widely according to regions. These estimates
cannot be compared to our estimate. We find lower chronic
disease burden for moderate drinkers and higher burden for
substantial drinkers. The relative distribution of drinking
habits in the population will determine the overall associ-
ation. We further focused on chronic diseases in an adult
population, while a younger populations with different
drinking patterns and the inclusion of accidents and liver
cirrhosis may affect population estimates. In the GBD
studies the disease burden of alcohol is highest for popu-
lations with a high proportion of heavy drinkers and thus a
high contribution of alcohol related diseases to disease
burden. Our study consists predominantly of middle-aged
or older women and included relatively few heavy drinkers,
leading to a low contribution of alcohol related conditions
to disease burden.
The net lower total disease burden of approximately
3 months among moderate drinkers compared with light
drinkers seems to be in line with evidence from cohort
studies showing a reduced risk of total mortality with
moderate alcohol consumption [5]. Two prospective cohort
studies related alcohol consumption to life expectancy
[31, 32]. Streppel et al. [32] showed that consuming B20 g
alcohol/day compared with no alcohol consumption was
associated with a 5-year longer life expectancy at age 50.
The effect size of this study was larger than we observed.
This may partly be due to the fact that the reference cat-
egory included former drinkers, while we excluded them
from the reference as they are likely to be sick-quitters
[33]. Li et al. [31] showed that heavy alcohol consumption
([4 drinks/day for men, [1 drinks/day for women) com-
pared with light consumption was associated with a
reduction of 4 years in life expectancy. Based on a life
table approach, Klijs et al. [34] also estimated that heavy
drinking was associated with approximately 2 years living
with disability. We found no relation with chronic disease
burden for substantial drinkers, but excessive drinking was
associated with alcohol related diseases.
In our study, disease burden associated with alcohol
consumption differed by age. The lower chronic disease
burden with moderate alcohol consumption was most
pronounced among participants aged 50 years and over,
and not observed among women aged \50 years. These
differences are mainly due to different diseases attributing
to disease burden. Since CVD account for the majority of
disease burden among older adults, the net association is
mainly driven by the association of alcohol consumption
and CVD. Women under age 50 years more frequently
suffer from breast cancer than CVD, resulting in a null net
association for alcohol consumption. In our study cancer
indeed accounted for approximately 60% of deaths among
women \50 years, while this was lower in the other
age/sex groups.
In conclusion, our results provide an estimate of the
contribution of alcohol consumption to disease burden over
a period of 12 years. The lower chronic disease burden
with moderate alcohol consumption supports the current
guidelines allowing moderate alcohol consumption up to
1 drink/day for women and up to 2 drinks/day for men and
discouraging higher levels of alcohol consumption [1–4].
However, our results suggest that the recommendations for
moderate alcohol consumption mainly apply to middle-
aged or older populations.
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